Access Bio
20 cited products
74 protocol citations
Access Bio is a leading provider of research products and solutions used across diverse scientific fields.
The company's portfolio includes a wide range of equipment, consumables, reagents, and chemicals tailored for various experimental protocols.
Access Bio's products are extensively cited in peer-reviewed publications, preprints, and patents, reflecting their utility and impact in advancing scientific discoveries.
Researchers can explore data on the applications and trends of Access Bio's solutions on PubCompare.ai to inform their research workflows and identify products that align with their specific needs.
The company's portfolio includes a wide range of equipment, consumables, reagents, and chemicals tailored for various experimental protocols.
Access Bio's products are extensively cited in peer-reviewed publications, preprints, and patents, reflecting their utility and impact in advancing scientific discoveries.
Researchers can explore data on the applications and trends of Access Bio's solutions on PubCompare.ai to inform their research workflows and identify products that align with their specific needs.
20 products from Access Bio
Sourced in United States
CareStart is a diagnostic device designed to detect the presence of specific analytes in a sample. It utilizes a technology that provides a qualitative result, indicating the presence or absence of the target analyte. The core function of CareStart is to serve as a tool for rapid analysis and screening purposes.
Sourced in United States
CareStart® Malaria is a rapid diagnostic test (RDT) developed by Access Bio. It is designed to detect the presence of malaria parasites in human blood samples. The test kit includes all necessary components for performing the test, including test devices, buffer, and other accessories.
Sourced in United States
The CareStart™ G6PD RDT is a rapid diagnostic test developed by Access Bio. It is designed to detect the presence of glucose-6-phosphate dehydrogenase (G6PD) enzyme in human blood samples.
Sourced in United States
The CareStart COVID-19 antigen tests are a diagnostic tool designed to detect the presence of SARS-CoV-2, the virus that causes COVID-19. The test utilizes a rapid, lateral flow immunoassay format to provide qualitative results. It is intended for the detection of specific viral antigens in nasal or nasopharyngeal swab specimens from individuals suspected of COVID-19 infection.
Sourced in United States
The CareStartTM Malaria HRP2/pLDH (Pf/PAN) Combo is a rapid diagnostic test kit developed by Access Bio. It is designed to detect the presence of Plasmodium falciparum-specific histidine-rich protein 2 (HRP2) and pan-Plasmodium-specific lactate dehydrogenase (pLDH) antigens in human blood samples.
Sourced in United States
The CareStart Malaria HRP2 (Pf) is a rapid diagnostic test that detects the presence of Plasmodium falciparum-specific histidine-rich protein 2 (HRP2) in human blood samples. It is designed to provide a qualitative result for the detection of P. falciparum malaria infection.
The RMPM-02571 is a laboratory equipment product manufactured by Access Bio. It is designed to perform specific functions within a laboratory setting. The core function of this product is to provide a controlled environment or process for various laboratory activities. No further details about its intended use or capabilities are provided, as per the instructions to maintain an unbiased and factual approach without interpretation or extrapolation.
Sourced in United States
The CareStart™ Malaria RDT is a rapid diagnostic test developed by Access Bio to detect the presence of malaria parasites in human blood samples. The test is designed to provide a qualitative result, indicating the presence or absence of the malaria parasite.
Sourced in United States
The CareStart™ Malaria Pf (HRP2) Ag RDT is a rapid diagnostic test designed to detect the presence of the Plasmodium falciparum (Pf) antigen in human blood samples. The test utilizes an immunochromatographic assay to provide a qualitative result, indicating the presence or absence of the Pf antigen.
Sourced in United States
The CareStart® Malaria Pf/Pv combo test is a rapid diagnostic test designed to detect Plasmodium falciparum and Plasmodium vivax, the two most common species of malaria parasites, in human blood samples.
About PubCompare
Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.
We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.
However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.
Ready to get started?
Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required
Revolutionizing how scientists
search and build protocols!